Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07945275
PHASE2

A Superiority Study of Model-Guided Optimized Dosing Versus Empirical Dosing of Piperacillin/Tazobactam in the Treatment of Community-Acquired Pneumonia in Elderly Patients

Sponsor: Shandong University

View on ClinicalTrials.gov

Summary

This study tests a new way to give an antibiotic to older adults with pneumonia. Pneumonia is a lung infection. Piperacillin-tazobactam is an antibiotic. Doctors often use it to treat pneumonia in older adults. Right now, doctors usually give this drug every 8 hours. They let it drip into the vein over 3 hours. But early research suggests a different schedule may work better. This study will test giving the drug every 6 hours. The drip will last 4 hours. Researchers think this may help the drug fight germs better. The study will compare the usual schedule with the new schedule. Participants will join one of two groups. One group will get the usual schedule. The other group will get the new schedule. Researchers will check how well the drug works. They will also watch for side effects. They want to find the safest and most helpful way to give this drug. Adults aged 65 and older with community-acquired pneumonia can join. Community-acquired pneumonia is a lung infection that starts outside of a hospital.

Official title: A Randomized Superiority Study Comparing Model-Guided Optimized Dosing With Empirical Dosing of Piperacillin/Tazobactam in Elderly Patients With Community-Acquired Pneumonia

Key Details

Gender

All

Age Range

65 Years - 110 Years

Study Type

INTERVENTIONAL

Enrollment

118

Start Date

2026-07-17

Completion Date

2027-05-31

Last Updated

2026-11-18

Healthy Volunteers

No

Interventions

DRUG

Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®)

Control arm (guideline-based conventional dosing): Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®) 4500 mg administered as a 3-hour intravenous infusion every 8 hours (q8h), for a total treatment course of 5-14 days.

OTHER

Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®)

Intervention arm (model-guided optimized dosing): Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®) 4500 mg administered as a 4-hour intravenous infusion every 6 hours (q6h), for a total treatment course of 5-14 days. This arm adopts increased dosing frequency and prolonged infusion duration compared with the control arm.

Locations (1)

Shandong Provincial Public Health Clinical Center

Jinan, Shandong, China